What is Inito?
Inito is pioneering the at-home diagnostics market with its innovative, smartphone-connected device capable of testing for a range of health indicators including fertility hormones, diabetes, and high cholesterol. Founded by Aayush Rai and Varun AV, the company empowers individuals to take control of their health by providing accessible and accurate personal health data. This focus on user-centric health management positions Inito as a key player in the burgeoning healthtech industry, offering a comprehensive solution for proactive wellness monitoring.
How much funding has Inito raised?
Inito has raised a total of $35M across 2 funding rounds:
Series A
$6M
Series B
$29M
Series A (2023): $6M with participation from Fireside Ventures
Series B (2025): $29M led by Bertelsmann India Investments and Fireside Ventures
Key Investors in Inito
Bertelsmann India Investments
Bertelsmann India Investments (BII) is a venture capital fund focused on early growth-stage tech startups across various sectors including healthtech, fintech, agritech, and edtech. With over $800 million in assets under management, BII invests between $5 million to $15 million in Series A to C funding rounds, supporting innovative companies like Emeritus, Licious, and Shiprocket. The firm emphasizes long-term partnerships and collaboration with leading VCs to empower entrepreneurs and help them scale their businesses. As the strategic investment arm of Bertelsmann SE & Co. KGaA in India, BII combines global reach with local insights to drive innovation and growth.
Fireside Ventures
Fireside Ventures is a leading venture capital firm in India that focuses on investing in health and consumer startups. The company aims to help founders build iconic consumer brands that create enduring value while fostering a sense of responsibility to the communities they serve. With a portfolio of over 64 brands and a managed capital of 5,300 Crores, Fireside Ventures emphasizes collaboration between visionary founders and committed investors. Their approach, known as The Fireside Way, is centered on the belief that doing well can be achieved by doing good together.
What's next for Inito?
The recent enterprise-level funding marks a pivotal moment for Inito, signaling a strong validation of its technology and market strategy. This capital is expected to fuel further product development, expand its diagnostic capabilities, and accelerate market penetration. With a clear trajectory from seed-stage development to scaling operations, Inito is poised to enhance its offerings and solidify its position as a leader in personalized health diagnostics, potentially exploring new testing modalities and strategic partnerships to broaden its impact.
See full Inito company page
